India's Wockhardt in fifth European acquisition

The Indian pharmaceutical company spends $265 million to acquire Negma Laboratories, a French research-based major with 172 patents.

To continue reading, please login or register for free

Print Edition

FinanceAsia Print Edition

CONFERENCES